Lataa...
Improved Protein Kinase C Affinity through Final Step Diversification of a Simplified Salicylate-Derived Bryostatin Analog Scaffold
[Image: see text] Bryostatin 1, in clinical trials or preclinical development for cancer, Alzheimer’s disease, and a first-of-its-kind strategy for HIV/AIDS eradication, is neither readily available nor optimally suited for clinical use. In preceding work, we disclosed a new class of simplified bryo...
Tallennettuna:
| Julkaisussa: | Org Lett |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Chemical Society
2014
|
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4334251/ https://ncbi.nlm.nih.gov/pubmed/25238640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ol502492b |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|